Literature DB >> 17913472

Metallo-beta-lactamase IMP-18 is located in a class 1 integron (In96) in a clinical isolate of Pseudomonas aeruginosa from Mexico.

U Garza-Ramos, P Tinoco, J Silva-Sanchez, R Morfin-Otero, E Rodriguez-Noriega, G Leon-Garnica, H S Sader, R N Jones.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17913472     DOI： 10.1016/j.ijantimicag.2007.08.003

Source DB:  PubMed          Journal:  Int J Antimicrob Agents        ISSN： 0924-8579            Impact factor:   5.283


× No keyword cloud information.
  10 in total

1.  Genetic context and biochemical characterization of the IMP-18 metallo-beta-lactamase identified in a Pseudomonas aeruginosa isolate from the United States.

Authors:  Luisa Borgianni; Silvia Prandi; Laurie Salden; Gisela Santella; Nancy D Hanson; Gian Maria Rossolini; Jean-Denis Docquier
Journal:  Antimicrob Agents Chemother       Date:  2010-11-01       Impact factor: 5.191

2.  Metallo-beta-lactamase gene bla(IMP-15) in a class 1 integron, In95, from Pseudomonas aeruginosa clinical isolates from a hospital in Mexico.

Authors:  U Garza-Ramos; R Morfin-Otero; H S Sader; R N Jones; E Hernández; E Rodriguez-Noriega; A Sanchez; B Carrillo; S Esparza-Ahumada; J Silva-Sanchez
Journal:  Antimicrob Agents Chemother       Date:  2008-05-19       Impact factor: 5.191

Review 3.  Platforms for antibiotic discovery.

Authors:  Kim Lewis
Journal:  Nat Rev Drug Discov       Date:  2013-05       Impact factor: 84.694

4.  Two novel class I integron arrays containing IMP-18 metallo-β-lactamase gene in Pseudomonas aeruginosa clinical isolates from Puerto Rico.

Authors:  T Martínez; G J Vazquez; E E Aquino; R V Goering; I E Robledo
Journal:  Antimicrob Agents Chemother       Date:  2012-01-30       Impact factor: 5.191

5.  Evolving carbapenemases: can medicinal chemists advance one step ahead of the coming storm?

Authors:  Peter Oelschlaeger; Ni Ai; Kevin T Duprez; William J Welsh; Jeffrey H Toney
Journal:  J Med Chem       Date:  2010-04-22       Impact factor: 7.446

6.  Surveillance of carbapenem-resistant Pseudomonas aeruginosa isolates from Puerto Rican Medical Center Hospitals: dissemination of KPC and IMP-18 beta-lactamases.

Authors:  Daniel J Wolter; Noha Khalaf; Iraida E Robledo; Guillermo J Vázquez; Maria I Santé; Edna E Aquino; Richard V Goering; Nancy D Hanson
Journal:  Antimicrob Agents Chemother       Date:  2009-02-02       Impact factor: 5.191

Review 7.  Epidemiology and Characteristics of Metallo-β-Lactamase-Producing Pseudomonas aeruginosa.

Authors:  Duck Jin Hong; Il Kwon Bae; In-Ho Jang; Seok Hoon Jeong; Hyun-Kyung Kang; Kyungwon Lee
Journal:  Infect Chemother       Date:  2015-06-30

8.  Carbapenem-Resistant Pseudomonas aeruginosa at US Emerging Infections Program Sites, 2015.

Authors:  Maroya Spalding Walters; Julian E Grass; Sandra N Bulens; Emily B Hancock; Erin C Phipps; Daniel Muleta; Jackie Mounsey; Marion A Kainer; Cathleen Concannon; Ghinwa Dumyati; Chris Bower; Jesse Jacob; P Maureen Cassidy; Zintars Beldavs; Karissa Culbreath; Walter E Phillips; Dwight J Hardy; Roberto L Vargas; Margret Oethinger; Uzma Ansari; Richard Stanton; Valerie Albrecht; Alison Laufer Halpin; Maria Karlsson; J Kamile Rasheed; Alexander Kallen
Journal:  Emerg Infect Dis       Date:  2019-07       Impact factor: 6.883

9.  High quality 3C de novo assembly and annotation of a multidrug resistant ST-111 Pseudomonas aeruginosa genome: Benchmark of hybrid and non-hybrid assemblers.

Authors:  José Arturo Molina-Mora; Rebeca Campos-Sánchez; César Rodríguez; Leming Shi; Fernando García
Journal:  Sci Rep       Date:  2020-01-29       Impact factor: 4.379

10.  Characterization of antimicrobial resistance mechanisms in carbapenem-resistant Pseudomonas aeruginosa carrying IMP variants recovered from a Mexican Hospital.

Authors:  Alma López-García; Rosa Del Carmen Rocha-Gracia; Elena Bello-López; Claudia Juárez-Zelocualtecalt; Yolanda Sáenz; Miguel Castañeda-Lucio; Liliana López-Pliego; María Cristina González-Vázquez; Carmen Torres; Teolincacihuatl Ayala-Nuñez; Guadalupe Jiménez-Flores; Margarita María de la Paz Arenas-Hernández; Patricia Lozano-Zarain
Journal:  Infect Drug Resist       Date:  2018-09-20       Impact factor: 4.003
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.